PRME Prime Medicine, Inc. - Common Stock
$2,78
Fiyat · May 20, 2026
Temel veriler itibarıyla May 7, 2026
52 Haftlık Aralık
$1–$7
29% of range
Analist Derecelendirmesi
BUY
19 analysts
Fiyat Hedefi
$7
+149% upside
P/E (TTM)
-2.6
ROE
-221.4%
Net Kâr Marjı
-4342.4%
PRME Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$2.78
Piyasa Değeri
$626M
P/E (TTM)
-2.6
EPS (TTM)
$-1.35
Gelir (TTM)
$5M
Temettü Verimi
—
ROE
-221.4%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $7
PRME Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$5M
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.35
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-167M
2022-12-31
→
2025-12-31
Marjlar
-4342.4%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
PRME
Akran Ortalaması
P/E (TTM)
-2.6
15.7
P/S (TTM) (F/S (TTM))
135.2
20.1
P/B (F/D)
5.2
4.1
Price / FCF (Fiyat / Serbest Nakit Akışı)
-3.7
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
PRME
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-4498.1%
—
Net Profit Margin (Net Kâr Marjı)
-4342.4%
-242.9%
ROA
-62.8%
-63.5%
ROE
-221.4%
-91.3%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
PRME
Akran Ortalaması
Current Ratio (Cari Oran)
4.8
4.6
Quick Ratio (Cari Oran)
1.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
PRME
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
55.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
-2.3%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
PRME
Akran Ortalaması
PRME Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
19 analist
- Güçlü Al 6 31,6%
- Al 8 42,1%
- Tut 5 26,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
9 analist · 2026-05-19
Medyan
$6.00
Ortalama
$6.92
← Tüm hedeflerin altında
$2.78
Düşük
$4.25
Yüksek
$11.00
Medyan hedef
$6.00
+115,8%
Ortalama hedef
$6.92
+148,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.04%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.28 | $-0.26 | -0.02% |
| 31 Aralık 2025 | $-0.26 | $-0.26 | -0.00% |
| 30 Eylül 2025 | $-0.32 | $-0.26 | -0.06% |
| 30 Haziran 2025 | $-0.41 | $-0.37 | -0.04% |
| 31 Mart 2025 | $-0.40 | $-0.33 | -0.07% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| XOMA | $315M | 18.2 | 83.1% | 60.8% | 43.5% | — |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
| ACHV | — | -4.0 | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $5M | $3M | $0 | $0 | $0 | |
| R&D Expense | $161M | $155M | $148M | $87M | $71M | |
| SG&A Expense | $52M | $50M | $43M | $30M | $14M | |
| Operating Expenses | $213M | $205M | $205M | $117M | $84M | |
| Operating Income | $-208M | $-202M | $-205M | $-117M | $-84M | |
| Interest Income | $4M | $4M | $3M | · | · | |
| Other Non-op | $148.0K | $41.0K | $274.0K | $2M | $12.0K | |
| Income Tax | $0 | $0 | $-279.0K | $-948.0K | $-486.0K | |
| Net Income | $-201M | $-196M | $-198M | $-122M | $-165M | |
| EPS (Basic) | $-1.35 | $-1.65 | $-2.18 | $-4.19 | $-14.19 | |
| EPS (Diluted) | $-1.35 | $-1.65 | $-2.18 | $-4.19 | $-14.19 | |
| Shares (Basic) | 148,758,527 | 118,600,381 | 90,969,327 | 33,891,264 | 12,973,495 | |
| Shares (Diluted) | 148,758,527 | 118,600,381 | 90,969,327 | 33,891,264 | 12,973,495 | |
| EBITDA | $-201M | $-196M | $-200M | $-114M | · |
Bilanço 22
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $182M | $42M | $188M | $185M | |
| Prepaid Expense | $3M | $7M | $19M | $2M | $959.0K | |
| Other Current Assets | $674.0K | $15M | $2M | $246.0K | · | |
| Current Assets | $181M | $212M | $143M | $297M | $271M | |
| PP&E (Net) | $21M | $24M | $23M | $19M | $5M | |
| PP&E (Gross) | $41M | $38M | $30M | $22M | $6M | |
| Accum. Depreciation | $20M | $14M | $7M | $3M | $611.0K | |
| Other Non-current Assets | $1M | $0 | $779.0K | $2M | $2M | |
| Total Assets | $343M | $298M | $194M | $360M | $302M | |
| Accounts Payable | $9M | $11M | $20M | $4M | $1M | |
| Accrued Liabilities | $13M | $16M | $14M | $11M | $37M | |
| Current Liabilities | $37M | $38M | $56M | $27M | $58M | |
| Capital Leases | $108M | $37M | $4M | $17M | $3M | |
| Deferred Tax | · | · | $0 | $279.0K | $1M | |
| Total Liabilities | $222M | $144M | $61M | $44M | $62M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $0 | |
| Paid-in Capital | $1.01B | $840M | $624M | $610M | $15M | |
| Retained Earnings | $-888M | $-687M | $-491M | $-293M | $-171M | |
| AOCI | $82.0K | $1.0K | $-15.0K | $-384.0K | $-27.0K | |
| Stockholders' Equity | $121M | $153M | $133M | $316M | $-156M | |
| Liabilities + Equity | $343M | $298M | $194M | $360M | $302M | |
| Shares Outstanding | 180,514,014 | 131,160,842 | 97,377,121 | 97,209,213 | 32,413,860 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $5M | $2M | $568.0K | |
| Stock-based Comp | $29M | $26M | $14M | $6M | $2M | |
| Deferred Tax | · | $0 | $-279.0K | $-964.0K | $-624.0K | |
| Other Non-cash | $2M | $41M | $14M | $-18M | · | |
| Operating Cash Flow | $-163M | $-123M | $-165M | $-132M | $-34M | |
| CapEx | $5M | $7M | $9M | $16M | $4M | |
| Investing Cash Flow | $-109M | $68M | $19M | $-47M | $-74M | |
| Stock Issued | $0 | $38M | $0 | · | · | |
| Net Stock Activity | $0 | $38M | · | · | · | |
| Financing Cash Flow | $152M | $196M | $655.0K | $181M | $269M | |
| Net Change in Cash | $-120M | $141M | $-146M | $3M | $162M | |
| Free Cash Flow | $-167M | $-130M | $-174M | $-148M | · |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -4498.1% | -6787.4% | · | · | · | |
| Net Margin | -4342.4% | -6566.6% | · | · | · | |
| EBITDA Margin | -4340.0% | -6581.9% | · | · | · | |
| ROA | -62.8% | -79.7% | -71.5% | -36.8% | · | |
| ROE | -221.4% | -114.3% | -121.2% | -261.5% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 5.6 | 2.5 | 11.1 | · | |
| Quick Ratio | 1.7 | 4.8 | 0.7 | 7.0 | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 55.3% | · | · | · | · | |
| Revenue CAGR 5Y | -2.3% | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $3M | $0 | $0 | · | |
| Net Income TTM | $-201M | $-196M | $-198M | $-122M | · | |
| Market Cap | $626M | $383M | $863M | $1.81B | · | |
| P/E | -2.6 | -1.8 | -4.1 | -4.4 | · | |
| P/S | 135.2 | 128.4 | · | · | · | |
| P/B | 5.2 | 2.5 | 6.5 | 5.7 | · | |
| P / Tangible Book | 5.2 | 2.5 | 6.5 | 5.7 | · | |
| P / Cash Flow | -3.9 | -3.1 | -5.2 | -13.7 | · | |
| P / FCF | -3.7 | -2.9 | -5.0 | -12.2 | · | |
| Earnings Yield | -38.9% | -56.5% | -24.6% | -22.6% | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $838.0K | $1M | $1M | $1M | $2M | $209.0K | $0 | $591.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $34M | $35M | $44M | $41M | $41M | $34M | $40M | $43M | $38M | $41M | $41M | $35M | $31M | |
| SG&A Expense | $17M | $15M | $11M | $13M | $13M | $12M | $14M | $13M | $11M | $13M | $10M | $11M | $9M | |
| Operating Expenses | $52M | $49M | $55M | $54M | $54M | $46M | $54M | $56M | $49M | $68M | $51M | $45M | $40M | |
| Operating Income | $-51M | $-49M | $-54M | $-53M | $-52M | $-44M | $-54M | $-56M | $-48M | $-68M | $-51M | $-45M | $-40M | |
| Interest Income | $1M | $1M | $1M | $743.0K | $1M | $2M | $697.0K | $611.0K | $676.0K | $491.0K | $410.0K | $635.0K | · | |
| Other Non-op | $51.0K | $49.0K | $44.0K | $18.0K | $37.0K | $43.0K | $-83.0K | $39.0K | $42.0K | $-2M | $43.0K | $41.0K | $2M | |
| Income Tax | · | · | · | $0 | $0 | $0 | $0 | $-134.0K | $134.0K | $0 | $-108.0K | $31.0K | $-202.0K | |
| Net Income | $-49M | $-46M | $-51M | $-53M | $-52M | $-42M | $-53M | $-55M | $-46M | $-66M | $-51M | $-42M | $-39M | |
| EPS (Basic) | $-0.28 | $-0.22 | $-0.32 | $-0.41 | $-0.40 | $-0.31 | $-0.44 | $-0.46 | $-0.44 | $-0.72 | $-0.55 | $-0.47 | $-0.44 | |
| EPS (Diluted) | $-0.28 | $-0.22 | $-0.32 | $-0.41 | $-0.40 | $-0.31 | $-0.44 | $-0.46 | $-0.44 | $-0.72 | $-0.55 | $-0.47 | $-0.44 | |
| Shares (Basic) | 177,096,225 | -271,815,064 | 160,503,183 | 129,185,918 | 130,884,490 | -224,818,933 | 119,764,270 | 119,188,866 | 104,466,178 | -180,409,701 | 91,846,835 | 90,467,298 | 89,064,895 | |
| Shares (Diluted) | 177,096,225 | -271,815,064 | 160,503,183 | 129,185,918 | 130,884,490 | -224,818,933 | 119,764,270 | 119,188,866 | 104,466,178 | -180,409,701 | 91,846,835 | 90,467,298 | 89,064,895 | |
| EBITDA | $-49M | · | $-52M | $-52M | $-51M | · | $-53M | $-54M | $-47M | · | $-50M | $-44M | $-39M |
Bilanço 22
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $63M | $71M | $54M | $92M | $182M | $118M | $56M | $94M | $42M | $44M | $121M | $133M | |
| Prepaid Expense | $2M | $3M | $2M | $3M | $3M | $7M | $6M | $4M | $4M | $19M | $19M | $11M | $4M | |
| Other Current Assets | $421.0K | $674.0K | $16M | $16M | $17M | $15M | $10M | $4M | $3M | $2M | · | · | · | |
| Current Assets | $138M | $181M | $231M | $121M | $164M | $212M | $246M | $171M | $218M | $143M | $185M | $218M | $254M | |
| PP&E (Net) | $19M | $21M | $22M | $24M | $25M | $24M | $23M | $24M | $24M | $23M | $22M | $21M | $22M | |
| PP&E (Gross) | $41M | $41M | $41M | $41M | $40M | $38M | $35M | $34M | $33M | $30M | $28M | $26M | $25M | |
| Accum. Depreciation | $22M | $20M | $19M | $17M | $15M | $14M | $12M | $10M | $9M | $7M | $6M | $5M | $4M | |
| Other Non-current Assets | $1M | $1M | · | · | · | $0 | $0 | $0 | $779.0K | $779.0K | $2M | $2M | $2M | |
| Total Assets | $295M | $343M | $385M | $279M | $328M | $298M | $333M | $260M | $311M | $194M | $239M | $281M | $317M | |
| Accounts Payable | $12M | $9M | $9M | $6M | $10M | $11M | $5M | $5M | $10M | $20M | $14M | $5M | $5M | |
| Accrued Liabilities | $8M | $13M | $11M | $12M | $9M | $16M | $19M | $11M | $8M | $14M | $14M | · | $8M | |
| Current Liabilities | $36M | $37M | $35M | $34M | $34M | $38M | $38M | $21M | $24M | $56M | $39M | $29M | $24M | |
| Capital Leases | $106M | $108M | $110M | $112M | $114M | $37M | $37M | $36M | $37M | $4M | $6M | $12M | $14M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $134.0K | · | $0 | $108.0K | $77.0K | |
| Total Liabilities | $218M | $222M | $223M | $218M | $221M | $144M | $143M | $63M | $68M | $61M | $45M | $41M | $38M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $1.01B | $1.01B | $1.00B | $853M | $846M | $840M | $834M | $789M | $781M | $624M | $620M | $615M | $612M | |
| Retained Earnings | $-937M | $-888M | $-842M | $-792M | $-739M | $-687M | $-645M | $-592M | $-537M | $-491M | $-426M | $-375M | $-333M | |
| AOCI | $-1.0K | $82.0K | $33.0K | $-10.0K | $-15.0K | $1.0K | $21.0K | $-71.0K | $-95.0K | $-15.0K | $-149.0K | $-268.0K | $-205.0K | |
| Stockholders' Equity | $77M | $121M | $162M | $61M | $107M | $153M | $190M | $197M | $244M | $133M | $194M | $240M | $279M | |
| Liabilities + Equity | $295M | $343M | $385M | $279M | $328M | $298M | $333M | $260M | $311M | $194M | $239M | $281M | $317M | |
| Shares Outstanding | 180,615,514 | 180,514,014 | 180,309,471 | 134,494,438 | 131,160,842 | 131,160,842 | 131,160,842 | 120,030,813 | 120,021,274 | 97,377,121 | 97,324,301 | 97,269,915 | 97,227,809 |
Nakit Akışı 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $5M | $5M | $13M | $6M | $6M | $6M | $7M | $8M | $5M | $4M | $4M | $4M | $2M | |
| Deferred Tax | · | · | · | $0 | $0 | · | $0 | $-134.0K | $134.0K | $0 | $-108.0K | $31.0K | $-202.0K | |
| Other Non-cash | $-88.0K | · | · | · | $-4M | · | · | · | $-29M | · | · | · | $-5M | |
| Operating Cash Flow | $-43M | $-37M | $-35M | $-41M | $-49M | $16M | $-26M | $-45M | $-68M | $-44M | $-39M | $-41M | $-42M | |
| CapEx | $214.0K | $290.0K | $247.0K | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Investing Cash Flow | $43M | $28M | $-92M | $3M | $-48M | $48M | $50M | $7M | $-37M | $41M | $-38M | $28M | $-13M | |
| Stock Issued | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $393.0K | $562.0K | $145M | $197.0K | $6M | $1.0K | $39M | $35.0K | $157M | $194.0K | $318.0K | $75.0K | $68.0K | |
| Net Change in Cash | $1M | $-8M | $18M | $-38M | $-91M | $64M | $63M | $-39M | $53M | $-2M | $-77M | $-13M | $-54M | |
| Free Cash Flow | $-43M | · | · | · | $-51M | · | · | · | $-70M | · | · | · | $-44M |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -4406.0% | -4787.2% | -3603.3% | · | -25948.3% | · | -8179.5% | · | · | · | · | |
| Net Margin | · | · | -4129.1% | -4716.7% | -3568.8% | · | -25128.2% | · | -7743.0% | · | · | · | · | |
| EBITDA Margin | · | · | -4252.4% | -4620.0% | -3486.4% | · | -25202.9% | · | -7957.0% | · | · | · | · | |
| ROA | -15.8% | · | -14.1% | -19.5% | -16.2% | · | -18.4% | -20.5% | -14.6% | · | -22.3% | -30.2% | -24.9% | |
| ROE | -53.5% | · | -28.8% | -40.9% | -29.6% | · | -27.4% | -25.3% | -17.5% | · | 348.0% | -35.3% | -28.3% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | · | 6.6 | 3.6 | 4.8 | · | 6.5 | 8.2 | 8.9 | · | 4.7 | 7.6 | 10.6 | |
| Quick Ratio | 1.8 | · | 2.0 | 1.6 | 2.7 | · | 3.1 | 2.7 | 3.9 | · | 1.1 | 4.2 | 5.6 |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | · | $4M | $3M | $2M | · | $800.0K | $591.0K | $591.0K | · | · | · | · | |
| Net Income TTM | $-204M | · | $-208M | $-212M | $-205M | · | $-204M | $-194M | $-178M | · | $-162M | $-140M | $-122M | |
| Market Cap | $629M | · | $999M | $332M | $261M | · | $508M | $617M | $840M | · | $928M | $1.43B | $1.20B | |
| P/E | -2.5 | · | -3.5 | -1.4 | -1.1 | · | -2.0 | -2.7 | -3.7 | · | -3.1 | -3.4 | -2.3 | |
| P/S | 157.0 | · | 249.5 | 119.6 | 115.8 | · | 634.5 | 1043.9 | 1421.6 | · | · | · | · | |
| P/B | 8.2 | · | 6.2 | 5.5 | 2.4 | · | 2.7 | 3.1 | 3.4 | · | 4.8 | 5.9 | 4.3 | |
| P / Tangible Book | 8.2 | · | 6.2 | 5.5 | 2.4 | · | 2.7 | 3.1 | 3.4 | · | 4.8 | 5.9 | 4.3 | |
| P / Cash Flow | -14.7 | · | · | · | -5.3 | · | · | · | -12.4 | · | · | · | -28.8 | |
| P / FCF | -14.6 | · | · | · | -5.1 | · | · | · | -12.0 | · | · | · | -27.5 | |
| Earnings Yield | -40.5% | · | -28.3% | -69.2% | -87.4% | · | -48.8% | -37.4% | -27.1% | · | -32.2% | -29.2% | -43.8% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $5M | $3M | $0 | $0 | $0 |
| Faaliyet Kâr Marjı % | -4498.1% | -6787.4% | — | — | — |
| Net Gelir | $-201M | $-196M | $-198M | $-122M | $-165M |
| Seyreltilmiş Hisse Başı Kâr | $-1.35 | $-1.65 | $-2.18 | $-4.19 | $-14.19 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 4.8 | 5.6 | 2.5 | 11.1 | — |
| Cari Oran | 1.7 | 4.8 | 0.7 | 7.0 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-167M | $-130M | $-174M | $-148M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.